Skip to main content

Table 1 Demographic data, pathology, Laterality, Visual accuity

From: Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients

NO.

Gender

Age

Pathology

Diagnosis time (eye after CNS)

Laterality

Initial VA

Latest VA

1

M

56

DLBCL

1 month

L

0.1

0.9

2

F

68

DLBCL

2 months

R

0.8

0.6

L

0.8

0.8

3

M

58

DLBCL

5 months

R

0.5

0.8

1 month

L

0.5

1.0

4

M

72

DLBCL

6 months

R

0.15

0.6

L

0.4

0.8

5

F

54

DLBCL

14 months

L

0.25

0.5

6

M

65

DLBCL

4 months

R

HM\BE

0.01

L

0.15

FC/20 cm

7

F

45

DLBCL

23 months

R

0.2

0.8

L

0.4

0.7

8

M

67

DLBCL

Concurrent

R

FC/20 cm

0.6

9

F

71

DLBCL

Concurrent

L

FC/20 cm

0.1

10

F

54

DLBCL

Concurrent

R

1.0

0.7

L

0.6

0.6

11

M

56

DLBCL

32 months

R

0.4

0.8

12

M

51

DLBCL

Concurrent

L

FC/20 cm

0.5

13

M

59

DLBCL

5 months

R

0.15

1.0

L

0.5

1.0

14

M

73

DLBCL

54 months

R

0.25

1.0

15

M

72

T cell lymphoma

2 months

R

0.6

0.8

L

0.6

0.8

16

F

42

DLBCL

Concurrent

R

1.0

1.0

17

M

53

DLBCL

Concurrent

L

0.6

0.6

18

F

55

DLBCL

Concurrent

R

0.5

0.6

L

0.5

0.8

19

F

65

DLBCL

Concurrent

R

0.3

0.7

L

0.3

0.7

20

F

61

DLBCL

Concurrent

R

0.4

0.9

21

F

65

DLBCL

3 months

L

0.1

22

M

53

DLBCL

22 months

R

0.8

L

0.8

  1. VA Visual acuity, M Male, F Female, R Right, L Left, DLBCL = diffuse large B-cell lymphoma, CNS Central nervous system, HM/BE Hand movement before eye, FC Finger count